Zilver® PTX® in China

NACompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

February 9, 2017

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Zilver® PTX® Drug-Eluting Peripheral Stent

Zilver® PTX® Drug-Eluting Peripheral Stent for treatment of lesions of the above-the-knee femoropopliteal artery

Trial Locations (9)

100029

Beijing Anzhen Hospital, Beijing

China-Japan Friendship Hospital, Beijing

100034

Peking University First Hospital, Beijing

100044

Peking University People's Hospital, Beijing

100730

Peking Union Medical College Hospital, Beijing

100853

Chinese PLA General Hospital, Beijing

200011

Shanghai Ninth People's Hospital Affiliated Shanghai JiaoTong University School of Medicine, Shanghai

200032

Zhongshan Hospital Fudan University, Shanghai

200127

Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Cook Group Incorporated

INDUSTRY

NCT02171962 - Zilver® PTX® in China | Biotech Hunter | Biotech Hunter